Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Bengtsson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods (San Diego, Calif.)|October 20, 1999
Immunomodulation by iscoms, immune stimulating complexesB Morein, K L Bengtsson
Immunology and Cell Biology|September 2, 1998
Functional aspects of iscomsF Morein, K L Bengtsson
Vaccine|June 1, 1996
Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvantK L Bengtsson, A Sjölander
Vaccine|June 1, 1997
Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteinsA Sjölander, K L Bengtsson, B Morein
Veterinary Immunology and Immunopathology|November 1, 1996
Novel adjuvants and vaccine delivery systemsB Morein, M Villacrés-Eriksson, A Sjölander, et al.
Vaccine|July 27, 1999
Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretionsJ Ekström, K F Hu, K L Bengtsson, et al.
Parasitology Research|January 1, 1997
Use of a recombinant antigen, SAG2, expressed as a glutathione-S-transferase fusion protein to immunize mice against Toxoplasma gondiiA Lundén, S F Parmley, K L Bengtsson, et al.
Vaccine|October 31, 1998
Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infectionA Sjölander, T M Baldwin, J M Curtis, et al.
Mechanisms of Ageing and Development|June 1, 1997
Influenza (H1N1)-ISCOMs enhance immune responses and protection in aged miceS Sambhara, S Woods, R Arpino, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods (San Diego, Calif.)|October 20, 1999
Immunomodulation by iscoms, immune stimulating complexesB Morein, K L Bengtsson
Immunology and Cell Biology|September 2, 1998
Functional aspects of iscomsF Morein, K L Bengtsson
Vaccine|June 1, 1996
Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvantK L Bengtsson, A Sjölander
Vaccine|June 1, 1997
Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteinsA Sjölander, K L Bengtsson, B Morein
Veterinary Immunology and Immunopathology|November 1, 1996
Novel adjuvants and vaccine delivery systemsB Morein, M Villacrés-Eriksson, A Sjölander, et al.
Vaccine|July 27, 1999
Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretionsJ Ekström, K F Hu, K L Bengtsson, et al.
Parasitology Research|January 1, 1997
Use of a recombinant antigen, SAG2, expressed as a glutathione-S-transferase fusion protein to immunize mice against Toxoplasma gondiiA Lundén, S F Parmley, K L Bengtsson, et al.
Vaccine|October 31, 1998
Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infectionA Sjölander, T M Baldwin, J M Curtis, et al.
Mechanisms of Ageing and Development|June 1, 1997
Influenza (H1N1)-ISCOMs enhance immune responses and protection in aged miceS Sambhara, S Woods, R Arpino, et al.
Pageof 1